Free
Brief Report  |   October 1997
New medical therapies in glaucoma management
Article Information
Brief Report   |   October 1997
New medical therapies in glaucoma management
The Journal of the American Osteopathic Association, October 1997, Vol. 97, 582. doi:10.7556/jaoa.1997.97.10.582
The Journal of the American Osteopathic Association, October 1997, Vol. 97, 582. doi:10.7556/jaoa.1997.97.10.582
Abstract

New and potent medications such as alpharadrenergic agonists, topically active carbonic anhydrase inhibitors, and prostaglandin analogs, are now available for use in the treatment of glaucoma. These ophthalmic medications have the potential to cause serious drug interactions and systemic side effects. The primary care physician should be able to recognize and to monitor any potential adverse effects and interact with the prescribing ophthalmologist for optimal patient care.